ASPSCR1 and neoplasm: The similar tumor suppression and angiogenesis phenotypes and gene expression profiles between ASPSCR1::TFE3 loss and the JQ1 treatment suggests the critical role of SEs modulated by ASPSCR1::TFE3, although the mechanism by which Brd4-inhibition targets certain SEs awaits clarification.